| Literature DB >> 33924387 |
Rosa S Wong1, Keith T S Tung1, Hung-Kwan So1, Wilfred H S Wong1, Siew Yan Wong1, Hing Wai Tsang1, Joanna Y L Tung1,2, Gilbert T Chua1, Marco H K Ho1, Ian C K Wong3,4, Patrick Ip1.
Abstract
Background: During the coronavirus disease 2019 (COVID-19) pandemic, the implementation of social distancing and home confinement measures may elevate the risk of vitamin D deficiency particularly for infants. This study aimed to quantify changes in vitamin D level among infants and toddlers in Hong Kong after the COVID-19 outbreak.Entities:
Keywords: COVID-19; infants; interrupted time series; serum 25-hydroxyvitamin D; vitamin D
Mesh:
Substances:
Year: 2021 PMID: 33924387 PMCID: PMC8069706 DOI: 10.3390/nu13041270
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Subject characteristics.
| Overall (n = 303) | 2–6 Months (n = 140) | 7–24 Months (n = 163) | ||||
|---|---|---|---|---|---|---|
| Age (months), mean (SD) | 10.42 (6.37) | 4.54 (1.52) | 15.47 (4.24) | |||
| Gender, n(%) | ||||||
| Male | 147 (48.51) | 70 (50.00) | 77 (47.24) | |||
| Female | 156 (51.49) | 70 (50.00) | 86 (52.76) | |||
| Serum 25(OH)D level (nmol/L) | n | mean(SD) | n | mean(SD) | n | mean(SD) |
|
|
|
|
|
|
|
|
| June 2019 | 10 | 69.51 (15.46) | 3 | 84.93 (5.46) | 7 | 62.90 (13.37) |
| July 2019 | 5 | 78.86 (17.71) | 2 | 68.15 (22.98) | 3 | 86.00 (13.12) |
| August 2019 | 44 | 61.02 (26.59) | 23 | 51.84 (27.13) | 21 | 71.08 (22.52) |
| September 2019 | 53 | 71.70 (24.68) | 34 | 66.97 (24.45) | 19 | 80.16 (23.35) |
| October 2019 | 36 | 68.60 (25.82) | 15 | 58.85 (23.32) | 21 | 75.57 (25.76) |
| November 2019 | 35 | 82.04 (38.43) | 16 | 76.54 (43.54) | 19 | 86.67 (34.06) |
|
|
|
|
|
|
|
|
| June 2020 | 4 | 63.35 (19.82) | 4 | 63.35 (19.81) | 0 | 0.00 (0.00) |
| July 2020 | 38 | 56.85 (21.08) | 22 | 52.51 (19.16) | 16 | 62.83 (22.73) |
| August 2020 | 19 | 66.28 (24.88) | 11 | 67.65 (24.96) | 8 | 64.39 (26.34) |
| September 2020 | 13 | 63.33 (12.47) | 2 | 76.59 (11.47) | 11 | 60.92 (11.48) |
| October 2020 | 25 | 60.49 (26.27) | 5 | 26.81 (15.87) | 20 | 68.91 (21.10) |
| November 2020 | 21 | 62.46 (12.72) | 3 | 57.83 (4.94) | 18 | 63.23 (13.53) |
Effect of time on serum 25(OH)D level in infants and toddlers in Hong Kong before and after the COVID-19 outbreak.
| Before the COVID-19 Outbreak (June to November 2019) | After the COVID-19 Outbreak (June to November 2020) | |||||
|---|---|---|---|---|---|---|
| Within-Group | Within-Group | Between-Group a | ||||
| β (95%CI) | β (95%CI) | β (95%CI) | ||||
| Overall (n = 303) | ||||||
| Unadjusted | 3.36 | 0.033 | 0.78 | 0.519 | −9.57 | 0.002 |
| Adjusted for age and sex | 3.30 | 0.032 | −0.63 | 0.631 | −11.16 | <0.001 |
| Additional adjustment for UV | 3.03 | 0.361 | −5.91 | 0.140 | −10.55 | <0.001 |
| Additional adjustment for UV and month | - | - | - | - | −10.79 | <0.001 |
| 2–6 months (n = 140) | ||||||
| Unadjusted | 2.93 | 0.251 | −2.58 | 0.296 | −8.57 | 0.083 |
| Adjusted for age and sex | 2.85 | 0.263 | −3.25 | 0.193 | −9.35 | 0.063 |
| Additional adjustment for UV | 1.88 | 0.720 | −13.39 | 0.015 | −7.24 | 0.217 |
| Additional adjustment for UV and month | - | - | - | - | −7.21 | 0.221 |
| 7–24 months (n = 163) | ||||||
| Unadjusted | 3.66 | 0.050 | 0.61 | 0.690 | −12.72 | <0.001 |
| Adjusted for age and sex | 3.88 | 0.038 | −0.40 | 0.798 | −12.83 | <0.001 |
| Additional adjustment for UV | 4.13 | 0.336 | 3.55 | 0.565 | −12.75 | <0.001 |
| Additional adjustment for UV and month | - | - | - | - | −13.34 | <0.001 |
a June to November 2019 (reference group) all coefficients are unstandardized. A p-value < 0.05 denotes statistical significance.
ITS analysis of trends in serum 25(OH)D level in infants and toddlers in Hong Kong before and after the COVID-19 outbreak.
| Model 1 | Model 2 a | Model 3 b | ||||
|---|---|---|---|---|---|---|
| β (95%CI) | β (95%CI) | β (95%CI) | ||||
| Overall (n = 303) | ||||||
| Time | 3.36 (0.58, 6.15) | 0.018 | 3.31 (0.59, 6.03) | 0.017 | 1.67 (−2.45, 5.80) | 0.425 |
| COVID-19 | −26.00 (−53.01, 1.01) | 0.059 | −12.67 (−39.93, 14.59) | 0.361 | 26.08 (−52.26, 104.42) | 0.513 |
| Time since COVID-19 | −2.59 (−6.60, 1.43) | 0.206 | −4.24 (−8.26, −0.22) | 0.039 | −6.32 (−11.95, −0.69) | 0.028 |
| 2–6 months (n = 140) | ||||||
| Time | 2.93 (−1.73, 7.58) | 0.216 | 2.96 (−1.67, 7.61) | 0.208 | −0.67 (−7.31, 5.96) | 0.841 |
| COVID-19 | 3.13 (−45.60, 51.86) | 0.899 | −0.24 (−48.86, 48.38) | 0.992 | 78.04 (−35.20, 191.27) | 0.175 |
| Time since COVID-19 | −5.50 (−12.99, 1.99) | 0.149 | −5.25 (−12.76, 2.26) | 0.169 | −9.02 (−17.98, −0.06) | 0.048 |
| 7–24 months (n = 163) | ||||||
| Time | 3.66 (0.39, 6.93) | 0.028 | 3.85 (0.63, 7.08) | 0.020 | 5.16 (−0.18, 10.49) | 0.058 |
| COVID-19 | −28.84 (−63.80, 6.12) | 0.105 | −23.87 (−59.06, 11.32) | 0.182 | −57.56 (−172.98, 57.87) | 0.326 |
| Time since COVID-19 | −3.06 (−7.89, 1.78) | 0.214 | −3.85 (−8.71, 1.00) | 0.119 | −1.91 (−9.91, 6.09) | 0.638 |
a Adjusted for age and sex; b further adjusted for UV; all coefficients are unstandardized. A p-value < 0.05 denotes statistical significance.
Figure 1Serum 25(OH)D levels in infants (a) overall; (b) aged 2–6 months; (c) aged 7–24 months recruited between 1 June 2019 and 30 November 2020.